0001209191-23-025285.txt : 20230421
0001209191-23-025285.hdr.sgml : 20230421
20230421204449
ACCESSION NUMBER: 0001209191-23-025285
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230419
FILED AS OF DATE: 20230421
DATE AS OF CHANGE: 20230421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MATTINGLY MARTIN A
CENTRAL INDEX KEY: 0001265782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36818
FILM NUMBER: 23837736
MAIL ADDRESS:
STREET 1: C/O TRIMERIS, INC.
STREET 2: 2530 MERIDIAN PARKWAY, 2ND FLOOR
CITY: DURHAM
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tracon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001394319
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 342037594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4350 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 800
CITY: San Diego
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-550-0780
MAIL ADDRESS:
STREET 1: 4350 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 800
CITY: San Diego
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: Tracon Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070324
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-19
0
0001394319
Tracon Pharmaceuticals, Inc.
TCON
0001265782
MATTINGLY MARTIN A
C/O TRACON PHARMACEUTICALS, INC.
4350 LA JOLLA VILLAGE DRIVE, SUITE 800
SAN DIEGO
CA
92122
1
0
0
0
0
Director Stock Option (Right to Buy)
1.82
2023-04-19
4
A
0
18000
0.00
A
2033-04-18
Common Stock
18000
18000
D
The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity
Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan).
/s/ Scott B. Brown, Attorney-in-Fact
2023-04-21